Global and United States C-MET / HGF Inhibitors Market Insights, Forecast to 2026
SKU ID : QYR-16371776 | Publishing Date : 04-Sep-2020
Detailed TOC of Global and United States C-MET / HGF Inhibitors Market Insights, Forecast to 2026
1 Study Coverage1.1 C-MET / HGF Inhibitors Product Introduction
1.2 Market Segments
1.3 Key C-MET / HGF Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by Type
1.4.2 C-Met Biologic Inhibitors
1.4.3 Small Molecule C-Met Inhibitors
1.4.4 HGF Antagonist Antibodies
1.4.5 C-Met Antagonist Antibodies(MetMAb)
1.4.6 HGF Kringle Variant Antagonists
1.5 Market by Application
1.5.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Online Sales
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global C-MET / HGF Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global C-MET / HGF Inhibitors Revenue 2015-2026
2.1.2 Global C-MET / HGF Inhibitors Sales 2015-2026
2.2 Global C-MET / HGF Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 C-MET / HGF Inhibitors Historical Market Size by Region (2015-2020)
2.3.1 Global C-MET / HGF Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global C-MET / HGF Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 C-MET / HGF Inhibitors Market Estimates and Projections by Region (2021-2026)
2.4.1 Global C-MET / HGF Inhibitors Sales Forecast by Region (2021-2026)
2.4.2 Global C-MET / HGF Inhibitors Revenue Forecast by Region (2021-2026)
3 Global C-MET / HGF Inhibitors Competitor Landscape by Players
3.1 Global Top C-MET / HGF Inhibitors Sales by Manufacturers
3.1.1 Global C-MET / HGF Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Global C-MET / HGF Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Global C-MET / HGF Inhibitors Manufacturers by Revenue
3.2.1 Global C-MET / HGF Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Global C-MET / HGF Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global C-MET / HGF Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by C-MET / HGF Inhibitors Revenue in 2019
3.2.5 Global C-MET / HGF Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global C-MET / HGF Inhibitors Price by Manufacturers
3.4 Global C-MET / HGF Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 C-MET / HGF Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers C-MET / HGF Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into C-MET / HGF Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global C-MET / HGF Inhibitors Market Size by Type (2015-2020)
4.1.1 Global C-MET / HGF Inhibitors Sales by Type (2015-2020)
4.1.2 Global C-MET / HGF Inhibitors Revenue by Type (2015-2020)
4.1.3 C-MET / HGF Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global C-MET / HGF Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global C-MET / HGF Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global C-MET / HGF Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 C-MET / HGF Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global C-MET / HGF Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global C-MET / HGF Inhibitors Market Size by Application (2015-2020)
5.1.1 Global C-MET / HGF Inhibitors Sales by Application (2015-2020)
5.1.2 Global C-MET / HGF Inhibitors Revenue by Application (2015-2020)
5.1.3 C-MET / HGF Inhibitors Price by Application (2015-2020)
5.2 C-MET / HGF Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global C-MET / HGF Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global C-MET / HGF Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global C-MET / HGF Inhibitors Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026
6.1.1 United States C-MET / HGF Inhibitors Sales YoY Growth 2015-2026
6.1.2 United States C-MET / HGF Inhibitors Revenue YoY Growth 2015-2026
6.1.3 United States C-MET / HGF Inhibitors Market Share in Global Market 2015-2026
6.2 United States C-MET / HGF Inhibitors Market Size by Players (International and Local Players)
6.2.1 United States Top C-MET / HGF Inhibitors Players by Sales (2015-2020)
6.2.2 United States Top C-MET / HGF Inhibitors Players by Revenue (2015-2020)
6.3 United States C-MET / HGF Inhibitors Historic Market Review by Type (2015-2020)
6.3.1 United States C-MET / HGF Inhibitors Sales Market Share by Type (2015-2020)
6.3.2 United States C-MET / HGF Inhibitors Revenue Market Share by Type (2015-2020)
6.3.3 United States C-MET / HGF Inhibitors Price by Type (2015-2020)
6.4 United States C-MET / HGF Inhibitors Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States C-MET / HGF Inhibitors Sales Forecast by Type (2021-2026)
6.4.2 United States C-MET / HGF Inhibitors Revenue Forecast by Type (2021-2026)
6.4.3 United States C-MET / HGF Inhibitors Price Forecast by Type (2021-2026)
6.5 United States C-MET / HGF Inhibitors Historic Market Review by Application (2015-2020)
6.5.1 United States C-MET / HGF Inhibitors Sales Market Share by Application (2015-2020)
6.5.2 United States C-MET / HGF Inhibitors Revenue Market Share by Application (2015-2020)
6.5.3 United States C-MET / HGF Inhibitors Price by Application (2015-2020)
6.6 United States C-MET / HGF Inhibitors Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States C-MET / HGF Inhibitors Sales Forecast by Application (2021-2026)
6.6.2 United States C-MET / HGF Inhibitors Revenue Forecast by Application (2021-2026)
6.6.3 United States C-MET / HGF Inhibitors Price Forecast by Application (2021-2026)
7 North America
7.1 North America C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026
7.2 North America C-MET / HGF Inhibitors Market Facts & Figures by Country
7.2.1 North America C-MET / HGF Inhibitors Sales by Country (2015-2020)
7.2.2 North America C-MET / HGF Inhibitors Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026
8.2 Europe C-MET / HGF Inhibitors Market Facts & Figures by Country
8.2.1 Europe C-MET / HGF Inhibitors Sales by Country
8.2.2 Europe C-MET / HGF Inhibitors Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026
9.2 Asia Pacific C-MET / HGF Inhibitors Market Facts & Figures by Country
9.2.1 Asia Pacific C-MET / HGF Inhibitors Sales by Region (2015-2020)
9.2.2 Asia Pacific C-MET / HGF Inhibitors Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026
10.2 Latin America C-MET / HGF Inhibitors Market Facts & Figures by Country
10.2.1 Latin America C-MET / HGF Inhibitors Sales by Country
10.2.2 Latin America C-MET / HGF Inhibitors Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026
11.2 Middle East and Africa C-MET / HGF Inhibitors Market Facts & Figures by Country
11.2.1 Middle East and Africa C-MET / HGF Inhibitors Sales by Country
11.2.2 Middle East and Africa C-MET / HGF Inhibitors Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abxign
12.1.1 Abxign Corporation Information
12.1.2 Abxign Description and Business Overview
12.1.3 Abxign Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abxign C-MET / HGF Inhibitors Products Offered
12.1.5 Abxign Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Corporation Information
12.2.2 Abbott Laboratories Description and Business Overview
12.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Laboratories C-MET / HGF Inhibitors Products Offered
12.2.5 Abbott Laboratories Recent Development
12.3 Amgen
12.3.1 Amgen Corporation Information
12.3.2 Amgen Description and Business Overview
12.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen C-MET / HGF Inhibitors Products Offered
12.3.5 Amgen Recent Development
12.4 ArQule
12.4.1 ArQule Corporation Information
12.4.2 ArQule Description and Business Overview
12.4.3 ArQule Sales, Revenue and Gross Margin (2015-2020)
12.4.4 ArQule C-MET / HGF Inhibitors Products Offered
12.4.5 ArQule Recent Development
12.5 Astex Therapeutics
12.5.1 Astex Therapeutics Corporation Information
12.5.2 Astex Therapeutics Description and Business Overview
12.5.3 Astex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Astex Therapeutics C-MET / HGF Inhibitors Products Offered
12.5.5 Astex Therapeutics Recent Development
12.6 AVEO Pharmaceuticals
12.6.1 AVEO Pharmaceuticals Corporation Information
12.6.2 AVEO Pharmaceuticals Description and Business Overview
12.6.3 AVEO Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AVEO Pharmaceuticals C-MET / HGF Inhibitors Products Offered
12.6.5 AVEO Pharmaceuticals Recent Development
12.7 Bristol-Myers Squibb(BMS)
12.7.1 Bristol-Myers Squibb(BMS) Corporation Information
12.7.2 Bristol-Myers Squibb(BMS) Description and Business Overview
12.7.3 Bristol-Myers Squibb(BMS) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bristol-Myers Squibb(BMS) C-MET / HGF Inhibitors Products Offered
12.7.5 Bristol-Myers Squibb(BMS) Recent Development
12.8 Chroma Therapeutics
12.8.1 Chroma Therapeutics Corporation Information
12.8.2 Chroma Therapeutics Description and Business Overview
12.8.3 Chroma Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Chroma Therapeutics C-MET / HGF Inhibitors Products Offered
12.8.5 Chroma Therapeutics Recent Development
12.9 Daiichi Sankyo
12.9.1 Daiichi Sankyo Corporation Information
12.9.2 Daiichi Sankyo Description and Business Overview
12.9.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Daiichi Sankyo C-MET / HGF Inhibitors Products Offered
12.9.5 Daiichi Sankyo Recent Development
12.10 Deciphera Pharmaceuticals
12.10.1 Deciphera Pharmaceuticals Corporation Information
12.10.2 Deciphera Pharmaceuticals Description and Business Overview
12.10.3 Deciphera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Deciphera Pharmaceuticals C-MET / HGF Inhibitors Products Offered
12.10.5 Deciphera Pharmaceuticals Recent Development
12.11 Abxign
12.11.1 Abxign Corporation Information
12.11.2 Abxign Description and Business Overview
12.11.3 Abxign Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abxign C-MET / HGF Inhibitors Products Offered
12.11.5 Abxign Recent Development
12.12 Eli Lilly
12.12.1 Eli Lilly Corporation Information
12.12.2 Eli Lilly Description and Business Overview
12.12.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Eli Lilly Products Offered
12.12.5 Eli Lilly Recent Development
12.13 Exelixis
12.13.1 Exelixis Corporation Information
12.13.2 Exelixis Description and Business Overview
12.13.3 Exelixis Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Exelixis Products Offered
12.13.5 Exelixis Recent Development
12.14 Genmab
12.14.1 Genmab Corporation Information
12.14.2 Genmab Description and Business Overview
12.14.3 Genmab Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Genmab Products Offered
12.14.5 Genmab Recent Development
12.15 Galaxy Biotech
12.15.1 Galaxy Biotech Corporation Information
12.15.2 Galaxy Biotech Description and Business Overview
12.15.3 Galaxy Biotech Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Galaxy Biotech Products Offered
12.15.5 Galaxy Biotech Recent Development
12.16 GlaxoSmithKline(GSK)
12.16.1 GlaxoSmithKline(GSK) Corporation Information
12.16.2 GlaxoSmithKline(GSK) Description and Business Overview
12.16.3 GlaxoSmithKline(GSK) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 GlaxoSmithKline(GSK) Products Offered
12.16.5 GlaxoSmithKline(GSK) Recent Development
12.17 Hutchison MediPharma
12.17.1 Hutchison MediPharma Corporation Information
12.17.2 Hutchison MediPharma Description and Business Overview
12.17.3 Hutchison MediPharma Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Hutchison MediPharma Products Offered
12.17.5 Hutchison MediPharma Recent Development
12.18 Johnson & Johnson
12.18.1 Johnson & Johnson Corporation Information
12.18.2 Johnson & Johnson Description and Business Overview
12.18.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Johnson & Johnson Products Offered
12.18.5 Johnson & Johnson Recent Development
12.19 Kringle Pharmaceuticals
12.19.1 Kringle Pharmaceuticals Corporation Information
12.19.2 Kringle Pharmaceuticals Description and Business Overview
12.19.3 Kringle Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Kringle Pharmaceuticals Products Offered
12.19.5 Kringle Pharmaceuticals Recent Development
12.20 Merck
12.20.1 Merck Corporation Information
12.20.2 Merck Description and Business Overview
12.20.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Merck Products Offered
12.20.5 Merck Recent Development
12.21 Methylgene
12.21.1 Methylgene Corporation Information
12.21.2 Methylgene Description and Business Overview
12.21.3 Methylgene Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Methylgene Products Offered
12.21.5 Methylgene Recent Development
12.22 Novartis
12.22.1 Novartis Corporation Information
12.22.2 Novartis Description and Business Overview
12.22.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Novartis Products Offered
12.22.5 Novartis Recent Development
12.23 Pfizer
12.23.1 Pfizer Corporation Information
12.23.2 Pfizer Description and Business Overview
12.23.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Pfizer Products Offered
12.23.5 Pfizer Recent Development
12.24 ProMetic BioTherapeutics
12.24.1 ProMetic BioTherapeutics Corporation Information
12.24.2 ProMetic BioTherapeutics Description and Business Overview
12.24.3 ProMetic BioTherapeutics Sales, Revenue and Gross Margin (2015-2020)
12.24.4 ProMetic BioTherapeutics Products Offered
12.24.5 ProMetic BioTherapeutics Recent Development
12.25 Takeda Pharmaceutical
12.25.1 Takeda Pharmaceutical Corporation Information
12.25.2 Takeda Pharmaceutical Description and Business Overview
12.25.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.25.4 Takeda Pharmaceutical Products Offered
12.25.5 Takeda Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key C-MET / HGF Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 C-MET / HGF Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States C-MET / HGF Inhibitors Market Insights, Forecast to 2026
List of TablesTable 1. C-MET / HGF Inhibitors Market Segments
Table 2. Ranking of Global Top C-MET / HGF Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global C-MET / HGF Inhibitors Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of C-Met Biologic Inhibitors
Table 5. Major Manufacturers of Small Molecule C-Met Inhibitors
Table 6. Major Manufacturers of HGF Antagonist Antibodies
Table 7. Major Manufacturers of C-Met Antagonist Antibodies(MetMAb)
Table 8. Major Manufacturers of HGF Kringle Variant Antagonists
Table 9. Global C-MET / HGF Inhibitors Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global C-MET / HGF Inhibitors Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global C-MET / HGF Inhibitors Sales by Regions 2015-2020 (K MT)
Table 12. Global C-MET / HGF Inhibitors Sales Market Share by Regions (2015-2020)
Table 13. Global C-MET / HGF Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global C-MET / HGF Inhibitors Sales Forecast by Region (2021-2026) (K MT)
Table 15. Global C-MET / HGF Inhibitors Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global C-MET / HGF Inhibitors Sales Share by Manufacturers (2015-2020)
Table 17. Global C-MET / HGF Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global C-MET / HGF Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-MET / HGF Inhibitors as of 2019)
Table 19. C-MET / HGF Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. C-MET / HGF Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers C-MET / HGF Inhibitors Price (2015-2020) (USD/MT)
Table 22. C-MET / HGF Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers C-MET / HGF Inhibitors Product Type
Table 24. Date of International Manufacturers Enter into C-MET / HGF Inhibitors Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global C-MET / HGF Inhibitors Sales by Type (2015-2020) (K MT)
Table 27. Global C-MET / HGF Inhibitors Sales Share by Type (2015-2020)
Table 28. Global C-MET / HGF Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 29. Global C-MET / HGF Inhibitors Revenue Share by Type (2015-2020)
Table 30. C-MET / HGF Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global C-MET / HGF Inhibitors Sales Share by Type (2021-2026)
Table 32. Global C-MET / HGF Inhibitors Sales by Application (2015-2020) (K MT)
Table 33. Global C-MET / HGF Inhibitors Sales Share by Application (2015-2020)
Table 34. Global C-MET / HGF Inhibitors Sales Share by Application (2021-2026)
Table 35. Global C-MET / HGF Inhibitors Sales Market Share Forecast by Application (2021-2026)
Table 36. Global C-MET / HGF Inhibitors Revenue by Application (2015-2020) (US$ Million)
Table 37. Global C-MET / HGF Inhibitors Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States C-MET / HGF Inhibitors Sales (K MT) of Key Companies (2015-2020)
Table 39. United States C-MET / HGF Inhibitors Sales Share by Company (2015-2020)
Table 40. United States C-MET / HGF Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 41. United States C-MET / HGF Inhibitors Sales (K MT) by Type (2015-2020)
Table 42. United States C-MET / HGF Inhibitors Sales Share by Type (2015-2020)
Table 43. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States C-MET / HGF Inhibitors Price (K MT) by Type (2015-2020)
Table 45. United States C-MET / HGF Inhibitors Sales (K MT) by Type (2021-2026)
Table 46. United States C-MET / HGF Inhibitors Sales Share by Type (2021-2026)
Table 47. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States C-MET / HGF Inhibitors Revenue Share by Type (2021-2026)
Table 49. United States C-MET / HGF Inhibitors Price (K MT) by Type (2021-2026)
Table 50. United States C-MET / HGF Inhibitors Sales (K MT) by Application (2015-2020)
Table 51. United States C-MET / HGF Inhibitors Sales Share by Application (2015-2020)
Table 52. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States C-MET / HGF Inhibitors Sales (K MT) by Application (2021-2026)
Table 54. United States C-MET / HGF Inhibitors Sales Share by Application (2021-2026)
Table 55. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States C-MET / HGF Inhibitors Revenue Share by Application (2021-2026)
Table 57. North America C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT)
Table 58. North America C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
Table 59. North America C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 60. North America C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
Table 61. Europe C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT)
Table 62. Europe C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
Table 63. Europe C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific C-MET / HGF Inhibitors Sales by Region (2015-2020) (K MT)
Table 66. Asia Pacific C-MET / HGF Inhibitors Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific C-MET / HGF Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific C-MET / HGF Inhibitors Revenue Market Share by Region (2015-2020)
Table 69. Latin America C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT)
Table 70. Latin America C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT)
Table 74. Middle East and Africa C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
Table 77. Abxign Corporation Information
Table 78. Abxign Description and Business Overview
Table 79. Abxign C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Abxign C-MET / HGF Inhibitors Product
Table 81. Abxign Recent Development
Table 82. Abbott Laboratories Corporation Information
Table 83. Abbott Laboratories Description and Business Overview
Table 84. Abbott Laboratories C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Abbott Laboratories Product
Table 86. Abbott Laboratories Recent Development
Table 87. Amgen Corporation Information
Table 88. Amgen Description and Business Overview
Table 89. Amgen C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Amgen Product
Table 91. Amgen Recent Development
Table 92. ArQule Corporation Information
Table 93. ArQule Description and Business Overview
Table 94. ArQule C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. ArQule Product
Table 96. ArQule Recent Development
Table 97. Astex Therapeutics Corporation Information
Table 98. Astex Therapeutics Description and Business Overview
Table 99. Astex Therapeutics C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Astex Therapeutics Product
Table 101. Astex Therapeutics Recent Development
Table 102. AVEO Pharmaceuticals Corporation Information
Table 103. AVEO Pharmaceuticals Description and Business Overview
Table 104. AVEO Pharmaceuticals C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AVEO Pharmaceuticals Product
Table 106. AVEO Pharmaceuticals Recent Development
Table 107. Bristol-Myers Squibb(BMS) Corporation Information
Table 108. Bristol-Myers Squibb(BMS) Description and Business Overview
Table 109. Bristol-Myers Squibb(BMS) C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Bristol-Myers Squibb(BMS) Product
Table 111. Bristol-Myers Squibb(BMS) Recent Development
Table 112. Chroma Therapeutics Corporation Information
Table 113. Chroma Therapeutics Description and Business Overview
Table 114. Chroma Therapeutics C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Chroma Therapeutics Product
Table 116. Chroma Therapeutics Recent Development
Table 117. Daiichi Sankyo Corporation Information
Table 118. Daiichi Sankyo Description and Business Overview
Table 119. Daiichi Sankyo C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Daiichi Sankyo Product
Table 121. Daiichi Sankyo Recent Development
Table 122. Deciphera Pharmaceuticals Corporation Information
Table 123. Deciphera Pharmaceuticals Description and Business Overview
Table 124. Deciphera Pharmaceuticals C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Deciphera Pharmaceuticals Product
Table 126. Deciphera Pharmaceuticals Recent Development
Table 127. Eisai Corporation Information
Table 128. Eisai Description and Business Overview
Table 129. Eisai C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Eisai Product
Table 131. Eisai Recent Development
Table 132. Eli Lilly Corporation Information
Table 133. Eli Lilly Description and Business Overview
Table 134. Eli Lilly C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 135. Eli Lilly Product
Table 136. Eli Lilly Recent Development
Table 137. Exelixis Corporation Information
Table 138. Exelixis Description and Business Overview
Table 139. Exelixis C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Exelixis Product
Table 141. Exelixis Recent Development
Table 142. Genmab Corporation Information
Table 143. Genmab Description and Business Overview
Table 144. Genmab C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 145. Genmab Product
Table 146. Genmab Recent Development
Table 147. Galaxy Biotech Corporation Information
Table 148. Galaxy Biotech Description and Business Overview
Table 149. Galaxy Biotech C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 150. Galaxy Biotech Product
Table 151. Galaxy Biotech Recent Development
Table 152. GlaxoSmithKline(GSK) Corporation Information
Table 153. GlaxoSmithKline(GSK) Description and Business Overview
Table 154. GlaxoSmithKline(GSK) C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 155. GlaxoSmithKline(GSK) Product
Table 156. GlaxoSmithKline(GSK) Recent Development
Table 157. Hutchison MediPharma Corporation Information
Table 158. Hutchison MediPharma Description and Business Overview
Table 159. Hutchison MediPharma C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 160. Hutchison MediPharma Product
Table 161. Hutchison MediPharma Recent Development
Table 162. Johnson & Johnson Corporation Information
Table 163. Johnson & Johnson Description and Business Overview
Table 164. Johnson & Johnson C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 165. Johnson & Johnson Product
Table 166. Johnson & Johnson Recent Development
Table 167. Kringle Pharmaceuticals Corporation Information
Table 168. Kringle Pharmaceuticals Description and Business Overview
Table 169. Kringle Pharmaceuticals C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 170. Kringle Pharmaceuticals Product
Table 171. Kringle Pharmaceuticals Recent Development
Table 172. Merck Corporation Information
Table 173. Merck Description and Business Overview
Table 174. Merck C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 175. Merck Product
Table 176. Merck Recent Development
Table 177. Methylgene Corporation Information
Table 178. Methylgene Description and Business Overview
Table 179. Methylgene C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 180. Methylgene Product
Table 181. Methylgene Recent Development
Table 182. Novartis Corporation Information
Table 183. Novartis Description and Business Overview
Table 184. Novartis C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 185. Novartis Product
Table 186. Novartis Recent Development
Table 187. Pfizer Corporation Information
Table 188. Pfizer Description and Business Overview
Table 189. Pfizer C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 190. Pfizer Product
Table 191. Pfizer Recent Development
Table 192. ProMetic BioTherapeutics Corporation Information
Table 193. ProMetic BioTherapeutics Description and Business Overview
Table 194. ProMetic BioTherapeutics C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 195. ProMetic BioTherapeutics Product
Table 196. ProMetic BioTherapeutics Recent Development
Table 197. Takeda Pharmaceutical Corporation Information
Table 198. Takeda Pharmaceutical Description and Business Overview
Table 199. Takeda Pharmaceutical C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 200. Takeda Pharmaceutical Product
Table 201. Takeda Pharmaceutical Recent Development
Table 202. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 203. Key Challenges
Table 204. Market Risks
Table 205. Main Points Interviewed from Key C-MET / HGF Inhibitors Players
Table 206. C-MET / HGF Inhibitors Customers List
Table 207. C-MET / HGF Inhibitors Distributors List
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. C-MET / HGF Inhibitors Product Picture
Figure 2. Global C-MET / HGF Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. C-Met Biologic Inhibitors Product Picture
Figure 4. Small Molecule C-Met Inhibitors Product Picture
Figure 5. HGF Antagonist Antibodies Product Picture
Figure 6. C-Met Antagonist Antibodies(MetMAb) Product Picture
Figure 7. HGF Kringle Variant Antagonists Product Picture
Figure 8. Global C-MET / HGF Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Drug Stores
Figure 12. Online Sales
Figure 13. C-MET / HGF Inhibitors Report Years Considered
Figure 14. Global C-MET / HGF Inhibitors Market Size 2015-2026 (US$ Million)
Figure 15. Global C-MET / HGF Inhibitors Sales 2015-2026 (K MT)
Figure 16. Global C-MET / HGF Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global C-MET / HGF Inhibitors Sales Market Share by Region (2015-2020)
Figure 18. Global C-MET / HGF Inhibitors Sales Market Share by Region in 2019
Figure 19. Global C-MET / HGF Inhibitors Revenue Market Share by Region (2015-2020)
Figure 20. Global C-MET / HGF Inhibitors Revenue Market Share by Region in 2019
Figure 21. Global C-MET / HGF Inhibitors Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by C-MET / HGF Inhibitors Revenue in 2019
Figure 23. C-MET / HGF Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global C-MET / HGF Inhibitors Sales Market Share by Type (2015-2020)
Figure 25. Global C-MET / HGF Inhibitors Sales Market Share by Type in 2019
Figure 26. Global C-MET / HGF Inhibitors Revenue Market Share by Type (2015-2020)
Figure 27. Global C-MET / HGF Inhibitors Revenue Market Share by Type in 2019
Figure 28. Global C-MET / HGF Inhibitors Market Share by Price Range (2015-2020)
Figure 29. Global C-MET / HGF Inhibitors Sales Market Share by Application (2015-2020)
Figure 30. Global C-MET / HGF Inhibitors Sales Market Share by Application in 2019
Figure 31. Global C-MET / HGF Inhibitors Revenue Market Share by Application (2015-2020)
Figure 32. Global C-MET / HGF Inhibitors Revenue Market Share by Application in 2019
Figure 33. United States C-MET / HGF Inhibitors Sales Growth Rate 2015-2026 (K MT)
Figure 34. United States C-MET / HGF Inhibitors Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States C-MET / HGF Inhibitors Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest C-MET / HGF Inhibitors Players Market Share by Revenue in C-MET / HGF Inhibitors in 2019
Figure 37. United States C-MET / HGF Inhibitors Revenue Share by Type (2015-2020)
Figure 38. United States C-MET / HGF Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States C-MET / HGF Inhibitors Revenue Share by Application (2015-2020)
Figure 40. United States C-MET / HGF Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 42. North America C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America C-MET / HGF Inhibitors Sales Market Share by Country in 2019
Figure 44. North America C-MET / HGF Inhibitors Revenue Market Share by Country in 2019
Figure 45. U.S. C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 46. U.S. C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 48. Canada C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 50. Europe C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe C-MET / HGF Inhibitors Sales Market Share by Country in 2019
Figure 52. Europe C-MET / HGF Inhibitors Revenue Market Share by Country in 2019
Figure 53. Germany C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 54. Germany C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 56. France C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 58. U.K. C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 60. Italy C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 62. Russia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 64. Asia Pacific C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific C-MET / HGF Inhibitors Sales Market Share by Region in 2019
Figure 66. Asia Pacific C-MET / HGF Inhibitors Revenue Market Share by Region in 2019
Figure 67. China C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 68. China C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 70. Japan C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 72. South Korea C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 74. India C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 76. Australia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 78. Taiwan C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 80. Indonesia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 82. Thailand C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 84. Malaysia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 86. Philippines C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 88. Vietnam C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America C-MET / HGF Inhibitors Sales Market Share by Country in 2019
Figure 92. Latin America C-MET / HGF Inhibitors Revenue Market Share by Country in 2019
Figure 93. Mexico C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa C-MET / HGF Inhibitors Sales Market Share by Country in 2019
Figure 102. Middle East and Africa C-MET / HGF Inhibitors Revenue Market Share by Country in 2019
Figure 103. Turkey C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. C-MET / HGF Inhibitors Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Keyplayers in Global and United States C-MET / HGF Inhibitors Market Insights, Forecast to 2026
AbxignAbbott Laboratories
Amgen
ArQule
Astex Therapeutics
AVEO Pharmaceuticals
Bristol-Myers Squibb(BMS)
Chroma Therapeutics
Daiichi Sankyo
Deciphera Pharmaceuticals
Eisai
Eli Lilly
Exelixis
Genmab
Galaxy Biotech
GlaxoSmithKline(GSK)
Hutchison MediPharma
Johnson & Johnson
Kringle Pharmaceuticals
Merck
Methylgene
Novartis
Pfizer
ProMetic BioTherapeutics
Takeda Pharmaceutical